Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report

<p></p><div> <p>Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.</p> </div><p></p><h2>Other Information</h2> <p> Publishe...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Elabbass A. Abdelmahmuod (14777296) (author)
مؤلفون آخرون: Elrazi Ali (14777284) (author), Mohanad A. Ahmed (14777299) (author), Mohamed A. Yassin (8361183) (author)
منشور في: 2023
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513566099374080
author Elabbass A. Abdelmahmuod (14777296)
author2 Elrazi Ali (14777284)
Mohanad A. Ahmed (14777299)
Mohamed A. Yassin (8361183)
author2_role author
author
author
author_facet Elabbass A. Abdelmahmuod (14777296)
Elrazi Ali (14777284)
Mohanad A. Ahmed (14777299)
Mohamed A. Yassin (8361183)
author_role author
dc.creator.none.fl_str_mv Elabbass A. Abdelmahmuod (14777296)
Elrazi Ali (14777284)
Mohanad A. Ahmed (14777299)
Mohamed A. Yassin (8361183)
dc.date.none.fl_str_mv 2023-03-16T06:19:21Z
dc.identifier.none.fl_str_mv 10.1002/ccr3.3783
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Eltrombopag_and_its_beneficial_role_in_management_of_ulcerative_Colitis_associated_with_ITP_as_an_upfront_therapy_case_report/22257613
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
General Medicine
dc.title.none.fl_str_mv Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p></p><div> <p>Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.</p> </div><p></p><h2>Other Information</h2> <p> Published in: Clinical Case Reports<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.3783" target="_blank">http://dx.doi.org/10.1002/ccr3.3783</a></p>
eu_rights_str_mv openAccess
id Manara2_87f35a0a261227fc5dea12bb8916d0a9
identifier_str_mv 10.1002/ccr3.3783
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/22257613
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case reportElabbass A. Abdelmahmuod (14777296)Elrazi Ali (14777284)Mohanad A. Ahmed (14777299)Mohamed A. Yassin (8361183)Biomedical and clinical sciencesClinical sciencesGeneral Medicine<p></p><div> <p>Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.</p> </div><p></p><h2>Other Information</h2> <p> Published in: Clinical Case Reports<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.3783" target="_blank">http://dx.doi.org/10.1002/ccr3.3783</a></p>2023-03-16T06:19:21ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ccr3.3783https://figshare.com/articles/journal_contribution/Eltrombopag_and_its_beneficial_role_in_management_of_ulcerative_Colitis_associated_with_ITP_as_an_upfront_therapy_case_report/22257613CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/222576132023-03-16T06:19:21Z
spellingShingle Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
Elabbass A. Abdelmahmuod (14777296)
Biomedical and clinical sciences
Clinical sciences
General Medicine
status_str publishedVersion
title Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_full Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_fullStr Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_full_unstemmed Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_short Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
title_sort Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
topic Biomedical and clinical sciences
Clinical sciences
General Medicine